Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SVANEKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.6% 3.6%   Bankruptcy risk   1.1% 1.2% 1.5% 1.1% 1.4% 1.7% 10.9% 10.9%   Credit score (0-100)   85 82 76 83 77 72 22 22   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   96.0 47.3 10.1 105.3 13.1 2.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,704 3,027 2,620 2,960 2,746 2,893 0.0 0.0   EBITDA   642 602 590 824 320 191 0.0 0.0   EBIT   638 598 586 817 320 191 0.0 0.0   Pre-tax profit (PTP)   637.8 610.9 595.5 834.8 334.7 199.4 0.0 0.0   Net earnings   494.6 472.9 460.9 647.1 257.2 151.8 0.0 0.0   Pre-tax profit without non-rec. items   638 611 595 835 335 199 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   15.9 11.8 7.8 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,435 1,408 1,369 1,516 1,123 1,025 800 800   Interest-bearing liabilities   95.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,275 2,288 2,652 2,475 1,817 1,921 800 800   Net Debt   -924 -419 -752 -548 -412 -324 -800 -800     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,704 3,027 2,620 2,960 2,746 2,893 0.0 0.0   Gross profit growth   8.0% 11.9% -13.4% 13.0% -7.2% 5.4% -100.0% 0.0%   Employees   4 4 4 4 4 5 0 0   Employee growth %   -20.0% 0.0% 0.0% 0.0% 0.0% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,275 2,288 2,652 2,475 1,817 1,921 800 800   Balance sheet change%   13.9% 0.6% 15.9% -6.7% -26.6% 5.7% -58.3% 0.0%   Added value   641.9 601.8 590.4 824.5 327.5 191.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -8 -8 -8 -16 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   23.6% 19.7% 22.4% 27.6% 11.6% 6.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.1% 27.0% 24.3% 32.8% 15.8% 10.9% 0.0% 0.0%   ROI %   43.3% 41.9% 43.2% 58.3% 25.8% 18.9% 0.0% 0.0%   ROE %   37.0% 33.3% 33.2% 44.9% 19.5% 14.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   63.1% 61.5% 51.6% 61.3% 61.8% 53.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -143.9% -69.6% -127.4% -66.4% -128.9% -169.5% 0.0% 0.0%   Gearing %   6.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 10.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.8 1.8 1.6 1.9 1.5 1.3 0.0 0.0   Current Ratio   2.6 2.5 2.0 2.5 2.6 2.1 0.0 0.0   Cash and cash equivalent   1,019.4 418.9 752.4 547.8 411.9 324.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,383.0 1,359.7 1,323.3 1,477.6 1,084.0 980.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   160 150 148 206 82 38 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   160 150 148 206 80 38 0 0   EBIT / employee   159 149 147 204 80 38 0 0   Net earnings / employee   124 118 115 162 64 30 0 0